Pictured: Collage of money and golden bull and bear/Nicole Bean for BioSpace
Skyrocketing weight-loss drug sales characterized the first quarter of 2024, with some companies beating Wall Street analysts’ earnings estimates, giving a clue to the current business environment and where things might be headed during…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
